Clinical effectiveness and affordability of the first "smart" wound care product featuring feedback-driven, polymeric dressing material take wound management to a radically new level.

Enluxtra represents a fundamentally new category of dynamic, multifunctional, self-adaptive wound care products. While in direct contact with the wound, the dressing material analyzes the wound condition; it then automatically and reversibly adjusts its function to accommodate the wound’s needs, which may frequently and unpredictably change.

Absorbed exudate and pathogens are locked inside the dressing, controlling infection and maceration; the dressing material releases moisture to dry areas of the wound, preventing desiccation. In effect, Enluxtra is suitable for any wound type at any healing stage.
"What’s impressive about this dressing is that you can use it from beginning to end on any wound," said Dr. Alex Reyzelman, the Co-Director of UCSF Center for Limb Preservation. "Now we can carry one product and use it on almost everything."

The super-absorptive dressing can be worn for up to 10 days, which results in both economic and clinical benefits. Reduced dressing change frequency brings significant cost savings to patients and healthcare providers, while fewer disruptions of wound homeostasis (a known critical condition for fast wound healing) aid uninterrupted healing process.

The impact Enluxtra can make on the economics of wound management stems from three major factors: inventory reduction, simplified training (even patients themselves can use the product), and reduced treatment duration.

In almost two years on the market, Enluxtra has been used by more than 40,000 patients both at home and in leading healthcare organizations and hundreds of facilities nationwide, including major hospitals, long-term care and skilled nursing facilities, nursing homes, home health agencies, wound care and podiatry clinics.